GlassScriptPhysician profile
Phillip M Mihm
NPI 1184667024
$816.72
in general payments reported to CMS, 2019-2025
10 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $19.92 · 2023: $19.14 · 2024: $315 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $225.02 | 2023-2025 | Illuccix |
| Canon Medical Systems USA, INC. | $176.78 | 2019 | |
| Ge Healthcare | $117.72 | 2020-2025 | |
| Progenics Pharmaceuticals, INC. | $74.84 | 2024-2025 | |
| Stryker Corporation | $70.37 | 2025 | Flowtriever |
| Hologic Sales and Service, LLC | $45.84 | 2024-2025 | Sertera Biopsy Device, 3dimensions |
| Novartis Pharmaceuticals Corporation | $34.42 | 2024 | |
| Eisai INC. | $27.70 | 2024 | |
| Cleerly, INC. | $22.55 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Leica Microsystems INC. | $21.48 | 2024 | Mammotome Elite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Mihm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.